SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sung-hee Han, Jonghun Lee, Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease, The Korean Journal of Gastroenterology, 2014, 63, 1, 3

    CrossRef

  2. 2
    M. S. Khuroo, Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy, Case Reports, 2014, 2014, may20 1, bcr2013203354

    CrossRef

  3. 3
    Angelo V. Marzano, Alessandro Borghi, Pier Luigi Meroni, Carlo Crosti, Massimo Cugno, Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy, Autoimmunity, 2014, 47, 3, 146

    CrossRef

  4. 4
    David S. Kotlyar, James D. Lewis, Laurent Beaugerie, Ann Tierney, Colleen M. Brensinger, Javier P. Gisbert, Edward V. Loftus, Laurent Peyrin-Biroulet, Wojciech C. Blonski, Manuel Van Domselaar, Maria Chaparro, Sandipani Sandilya, Meenakshi Bewtra, Florian Beigel, Livia Biancone, Gary R. Lichtenstein, Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis, Clinical Gastroenterology and Hepatology, 2014,

    CrossRef

  5. 5
    Jason M. Swoger, Miguel Regueiro, Stopping, Continuing, or Restarting Immunomodulators and Biologics When an Infection or Malignancy Develops, Inflammatory Bowel Diseases, 2014, 20, 5, 926

    CrossRef

  6. 6
    C. Castaño-Milla, M. Chaparro, J. P. Gisbert, Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 7
  7. 7
    Tine Jess, Anthony Lopez, Mikael Andersson, Laurent Beaugerie, Laurent Peyrin-Biroulet, Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis, Clinical Gastroenterology and Hepatology, 2014,

    CrossRef

  8. 8
    Soo Min Ahn, Seong O Suh, Yu Mi Oh, Chang Yong Yun, Hyoung Hun Sim, Chae A Park, Cheol Min Song, Ji Yoon Bae, A Case of Pleomorphic Liposarcoma in a Patient with Crohn's Disease Taking Azathioprine, The Korean Journal of Gastroenterology, 2013, 62, 4, 248

    CrossRef

  9. 9
    Mysha Mason, Corey A. Siegel, Do Inflammatory Bowel Disease Therapies Cause Cancer?, Inflammatory Bowel Diseases, 2013, 19, 6, 1306

    CrossRef

  10. 10
    Norimasa Fukata, Kazuichi Okazaki, Mika Omiya, Mitsunobu Matsushita, Mamoru Watanabe, Hematologic malignancies in the Japanese patients with inflammatory bowel disease, Journal of Gastroenterology, 2013,

    CrossRef

  11. 11
    Kavitha Subramaniam, James D'Rozario, Paul Pavli, Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review, Journal of Gastroenterology and Hepatology, 2013, 28, 1
  12. 12
    Laurent Beaugerie, Magali Svrcek, Philippe Seksik, Anne–Marie Bouvier, Tabassome Simon, Matthieu Allez, Hedia Brixi, Jean–Marc Gornet, Romain Altwegg, Philippe Beau, Bernard Duclos, Arnaud Bourreille, Jean Faivre, Laurent Peyrin–Biroulet, Jean–François Fléjou, Fabrice Carrat, Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease, Gastroenterology, 2013, 145, 1, 166

    CrossRef

  13. 13
    B. Pasternak, H. Svanstrom, K. Schmiegelow, T. Jess, A. Hviid, Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease, American Journal of Epidemiology, 2013, 177, 11, 1296

    CrossRef

  14. 14
    Kyoung Chan Park, Dong Uk Ju, Seong Wook Heo, Jung Il Ryu, Ju Youn Cho, Eui Jung Kim, Hoon Kyu Oh, Eun Young Kim, A Case of Squamous Cell Carcinoma of the Breast in a Patient with Crohn's Disease Taking Azathioprine, The Korean Journal of Gastroenterology, 2012, 60, 6, 373

    CrossRef

  15. 15
    Shane M. Devlin, Do thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease or is this an unanswerable question?, Inflammatory Bowel Diseases, 2012, 18, 6
  16. 16
    Chang Hwan Choi, Young-Ho Kim, You Sun Kim, Byong Duk Ye, Kang Moon Lee, Bo In Lee, Sung-Ae Jung, Won Ho Kim, Heeyoung Lee, Guidelines for the Management of Ulcerative Colitis, The Korean Journal of Gastroenterology, 2012, 59, 2, 118

    CrossRef

  17. 17
    Chang Hwan Choi, Young-Ho Kim, You Sun Kim, Byong Duk Ye, Kang Moon Lee, Bo In Lee, Sung-Ae Jung, Won Ho Kim, Heeyoung Lee, Guidelines for the Management of Ulcerative Colitis, Intestinal Research, 2012, 10, 1, 1

    CrossRef

  18. 18
    Meenakshi Bewtra, Lymphoma in Inflammatory Bowel Disease and Treatment Decisions, The American Journal of Gastroenterology, 2012, 107, 7, 964

    CrossRef

  19. 19
    Lori A. Ashworth, Amy Billett, Paul Mitchell, Federica Nuti, Corey Siegel, Athos Bousvaros, Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort, Inflammatory Bowel Diseases, 2012, 18, 5
  20. 20
    Filipe Vilas-Boas, Fernando Magro, Rui Balhau, José M. Lopes, Francisco Beça, Catarina Eloy, Susana Lopes, Guilherme Macedo, Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature, Journal of Crohn's and Colitis, 2012, 6, 7, 792

    CrossRef

  21. 21
    Keith Sultan, Burton I. Korelitz, Daniel Present, Seymour Katz, Suzanne Sunday, Iuliana Shapira, Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease, Inflammatory Bowel Diseases, 2012, 18, 10
  22. 22
    Mashiko Setshedi, David Epstein, Trevor A Winter, Landon Myer, Gillian Watermeyer, Richard Hift, Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study, Journal of Gastroenterology and Hepatology, 2012, 27, 2
  23. 23
    Venkataraman Subramanian, Richard F. Logan, Chemoprevention of colorectal cancer in inflammatory bowel disease, Best Practice & Research Clinical Gastroenterology, 2011, 25, 4-5, 593

    CrossRef

  24. 24
    Byong Duk Ye, Inflammatory Bowel Disease and Lymphoproliferative Disorders, The Korean Journal of Gastroenterology, 2011, 58, 4, 171

    CrossRef

  25. 25
    Jean-Baptiste Chevaux, Laurent Peyrin-Biroulet, Miles P. Sparrow, Optimizing thiopurine therapy in inflammatory bowel disease, Inflammatory Bowel Diseases, 2011, 17, 6
  26. 26
    Laura Riello, Cécile Talbotec, Hélène Garnier-Lengliné, Bénédicte Pigneur, Johan Svahn, Danielle Canioni, Olivier Goulet, Jacques Schmitz, Frank M. Ruemmele, Tolerance and efficacy of azathioprine in pediatric Crohn's disease, Inflammatory Bowel Diseases, 2011, 17, 10
  27. 27
    Katarzyna Elandt, Daniel Aletaha, Treating rheumatic patients with a malignancy, Arthritis Research & Therapy, 2011, 13, 3, 223

    CrossRef

  28. 28
    Daniel E. Furst, Eresha Markalanda, Philip J. Clements, Rheumatology, 2011,

    CrossRef

  29. 29
    Francis A. Farraye, Robert D. Odze, Jayne Eaden, Steven H. Itzkowitz, AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease, Gastroenterology, 2010, 138, 2, 746

    CrossRef

  30. 30
    S Loganathan, A Zaitoun, CPJ Charlton, Lymphoma With Central Nervous System Involvement in a Young Patient With Crohn Disease Treated With Azathioprine, Journal of Pediatric Gastroenterology and Nutrition, 2010, 51, 6, 790

    CrossRef

  31. 31
    Alessandra Aldinucci, Tiziana Biagioli, Cinzia Manuelli, Anna Maria Repice, Luca Massacesi, Clara Ballerini, Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: A novel mechanism of AZA/6-MP, Journal of Neuroimmunology, 2010, 218, 1-2, 28

    CrossRef

  32. You have free access to this content32
    M. A. Smith, P. M. Irving, A. M. Marinaki, J. D. Sanderson, Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2010, 32, 2
  33. 33
    Meenakshi Bewtra, James D. Lewis, Safety Profile of IBD: Lymphoma Risks, Medical Clinics of North America, 2010, 94, 1, 93

    CrossRef

  34. 34
    Christina Ha, Themistocles Dassopoulos, Thiopurine therapy in inflammatory bowel disease, Expert Review of Gastroenterology & Hepatology, 2010, 4, 5, 575

    CrossRef

  35. 35
    Meenakshi Bewtra, James D Lewis, Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease, Expert Review of Clinical Immunology, 2010, 6, 4, 621

    CrossRef

  36. 36
    Meyler's Side Effects of Drugs in Cancer and Immunology, 2010,

    CrossRef

  37. 37
    Xavier Treton, Yoram Bouhnik, Jean–Yves Mary, Jean–Frédéric Colombel, Bernard Duclos, Jean–Claude Soule, Eric Lerebours, Jacques Cosnes, Marc Lemann, Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse, Clinical Gastroenterology and Hepatology, 2009, 7, 1, 80

    CrossRef

  38. 38
    Hideaki Miura, Takaaki Kawaguchi, Masakazu Takazoe, Shigehiro Kitamura, Haruki Yamada, Hepatocellular Carcinoma and Crohn's Disease: A Case Report and Review, Internal Medicine, 2009, 48, 10, 815

    CrossRef

  39. 39
    Meenakshi Bewtra, James D. Lewis, Safety Profile of IBD: Lymphoma Risks, Gastroenterology Clinics of North America, 2009, 38, 4, 669

    CrossRef

  40. 40
    John H. Kempen, Sapna Gangaputra, Ebenezer Daniel, Grace A. Levy-Clarke, Robert B. Nussenblatt, James T. Rosenbaum, Eric B. Suhler, Jennifer E. Thorne, C. Stephen Foster, Douglas A. Jabs, Kathy J. Helzlsouer, Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the Evidence, American Journal of Ophthalmology, 2008, 146, 6, 802

    CrossRef

  41. 41
    A. LAU, N. CHANDE, T. PONICH, J. C. GREGOR, Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case–control study, Alimentary Pharmacology & Therapeutics, 2008, 28, 5
  42. 42
    Kazuki Kakimoto, Takuya Inoue, Takashi Nishikawa, Kumi Ishida, Ken Kawakami, Takanori Kuramoto, Yosuke Abe, Eijiro Morita, Naoko Murano, Ken Toshina, Mitsuyuki Murano, Eiji Umegaki, Yutaro Egashira, Junji Okuda, Nobuhiko Tanigawa, Ichiro Hirata, Ken-Ichi Katsu, Kazuhide Higuchi, Primary CD56+ NK/T-cell lymphoma of the rectum accompanied with refractory ulcerative colitis, Journal of Gastroenterology, 2008, 43, 7, 576

    CrossRef

  43. 43
    Cheryl Cameron, Larry Greenbaum, Thomas Sato, Beth Trost, Brian Lundeen, Michael E. Kelly, Renal cell carcinoma in a patient with cystinosis and inflammatory bowel disease: a case report, Pediatric Nephrology, 2008, 23, 7, 1167

    CrossRef

  44. 44
    Murat Toruner, Edward V. Loftus, W. Scott Harmsen, Alan R. Zinsmeister, Robert Orenstein, William J. Sandborn, Jean–Frederic Colombel, Laurence J. Egan, Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease, Gastroenterology, 2008, 134, 4, 929

    CrossRef

  45. 45
    Jason Samarasena, Mark Borgaonkar, Development of Hepatocellular Carcinoma in a Patient with Crohn’s Disease Treated with Azathioprine, Digestive Diseases and Sciences, 2007, 52, 10, 2748

    CrossRef

  46. 46
    Jennifer L. Jones, Edward V. Loftus, Lymphoma risk in inflammatory bowel disease: Is it the disease or its treatment?, Inflammatory Bowel Diseases, 2007, 13, 10
  47. 47
    F. Kästner, W. Paulus, M. Deckert, P. Schlegel, S. Evers, I.W. Husstedt, Primäres ZNS-Lymphom während der Behandlung von Autoimmunerkrankungen mit Azathioprin, Der Nervenarzt, 2007, 78, 4, 451

    CrossRef

  48. 48
    Eva Baecklund, Anastasia Iliadou, Johan Askling, Anders Ekbom, Carin Backlin, Fredrik Granath, Anca Irinel Catrina, Richard Rosenquist, Nils Feltelius, Christer Sundström, Lars Klareskog, Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis, Arthritis & Rheumatism, 2006, 54, 3
  49. 49
    Simon J Meggitt, Janine C Gray, Nick J Reynolds, Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial, The Lancet, 2006, 367, 9513, 839

    CrossRef

  50. 50
    Akash A. Patel, Robert A. Swerlick, Calvin O. McCall, Azathioprine in dermatology: The past, the present, and the future, Journal of the American Academy of Dermatology, 2006, 55, 3, 369

    CrossRef

  51. 51
    Sonia Friedman, Cancer in Crohn's Disease, Gastroenterology Clinics of North America, 2006, 35, 3, 621

    CrossRef

  52. 52
    Richard C. Cabot, Nancy Lee Harris, Jo-Anne O. Shepard, Sally H. Ebeling, Christine C. Peters, Daniel K. Podolsky, R. Gilberto Gonzalez, Robert P. Hasserjian, Case 8-2006, New England Journal of Medicine, 2006, 354, 11, 1178

    CrossRef

  53. 53
    Erick P. Chan, Gary R. Lichtenstein, Chemoprevention: Risk Reduction with Medical Therapy of Inflammatory Bowel Disease, Gastroenterology Clinics of North America, 2006, 35, 3, 675

    CrossRef

  54. 54
    J. F. Owe, A. K. Daltveit, N. E. Gilhus, Does myasthenia gravis provide protection against cancer?, Acta Neurologica Scandinavica, 2006, 113,
  55. 55
    M.V. García-Sánchez, A. Poyato-González, M.D. Giráldez-Jiménez, F. Gómez-Camacho, A. Espigares del Águila, J.F. de Dios-Vega, Linfoma intestinal tipo MALT en una paciente con enfermedad de Crohn: ¿asociación causal o casual?, Gastroenterología y Hepatología, 2006, 29, 2, 74

    CrossRef

  56. 56
    F.J. Moloney, P. Dicker, P.J. Conlon, D.C Shields, G.M. Murphy, The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients, British Journal of Dermatology, 2006, 154, 6
  57. 57
    Alan C Moss, Aoife M Brennan, Adam S Cheifetz, Mark A Peppercorn, Thyroid cancer and Crohn's disease: Association or coincidence?, Inflammatory Bowel Diseases, 2006, 12, 1
  58. 58
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  59. 59
    Marc Lémann, Jean-Yves Mary, Jean-Frédéric Colombel, Bernard Duclos, Jean-Claude Soule, Eric Lerebours, Robert Modigliani, Yoram Bouhnik, A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine, Gastroenterology, 2005, 128, 7, 1812

    CrossRef

  60. 60
    Tomonobu Sato, Ryoji Kobayashi, Akihiro Iguchi, Masahide Nakajima, Saeko Koizumi, Hiroyuki Furukawa, Satoru Todoh, Kunihiko Kobayashi, Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls, Leukemia & Lymphoma, 2005, 46, 7, 1057

    CrossRef

  61. 61
    Netta Levin, Oded Abramsky, Alexander Lossos, Dimitrios Karussis, Tali Siegal, Zohar Argov, Tamir Ben Hur, Extrathymic malignancies in patients with myasthenia gravis, Journal of the Neurological Sciences, 2005, 237, 1-2, 39

    CrossRef

  62. 62
    Meena Thayu, Jonathan E. Markowitz, Petar Mamula, Pierre A. Russo, William I. Muinos, Robert N. Baldassano, Hepatosplenic T-Cell Lymphoma in an Adolescent Patient after Immunomodulator and Biologic Therapy for Crohn Disease, Journal of Pediatric Gastroenterology and Nutrition, 2005, 40, 2, 220

    CrossRef

  63. 63
    Nikhil Thapar, Neil Shah, Alan D Ramsay, Keith J Lindley, Peter J Milla, Long-Term Outcome of Intractable Ulcerating Enterocolitis of Infancy, Journal of Pediatric Gastroenterology and Nutrition, 2005, 40, 5, 582

    CrossRef

  64. 64
    K. M. Getliffe, D. Al Dulaimi, C. Martin-Ruiz, R. L. Holder, T. Von Zglinicki, A. Morris, C. U. Nwokolo, Lymphocyte telomere dynamics and telomerase activity in inflammatory bowel disease: effect of drugs and smoking, Alimentary Pharmacology & Therapeutics, 2005, 21, 2
  65. 65
    C. A. SIEGEL, B. E. SANDS, Review article: practical management of inflammatory bowel disease patients taking immunomodulators, Alimentary Pharmacology & Therapeutics, 2005, 22, 1
  66. 66
    John H. Kwon, Richard J. Farrell, The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents, Critical Reviews in Oncology/Hematology, 2005, 56, 1, 169

    CrossRef

  67. 67
    Dana Kazlow Stern, Jackie M. Tripp, Vincent C. Ho, Mark Lebwohl, The Use of Systemic Immune Moderators in Dermatology: An Update, Dermatologic Clinics, 2005, 23, 2, 259

    CrossRef

  68. 68
    Seymour Katz, Update in Medical Therapy of Ulcerative Colitis, Journal of Clinical Gastroenterology, 2005, 39, 7, 557

    CrossRef

  69. 69
    Eric M. Silberhorn, Encyclopedia of Toxicology, 2005,

    CrossRef

  70. 70
    Karen L. Krok, Gary R. Lichtenstein, Colorectal cancer in inflammatory bowel disease, Current Opinion in Gastroenterology, 2004, 20, 1, 43

    CrossRef

  71. 71
    Alessandra Losco MD, Umberto Gianelli, Barbara Cassani, Luca Baldini, Dario Conte MD, Guido Basilisco, Epstein-Barr virus-associated lymphoma in Crohn's disease, Inflammatory Bowel Diseases, 2004, 10, 4
  72. 72
    Pierre Desreumaux, Immunosuppresseurs et MICI, Gastroentérologie Clinique et Biologique, 2004, 28, 8-9, 685

    CrossRef

  73. 73
    Juliette Tchuenbou, Anne De Muret, Pascal Dumont, Yannick Bacq, Maladie de Hodgkin au cours d’un traitement par azathioprine (Imurel®) pour hépatite chronique auto-immune, Gastroentérologie Clinique et Biologique, 2004, 28, 3, 316

    CrossRef

  74. 74
    Jean-Marie Reimund, Bruno Bonaz, Michel Gompel, Francis Michot, Jacques Moreau, Michel Veyrac, Jacques Wagner Ballon, Traitement préventif de la rechute au cours de la rectocolite ulcéro-hémorragique, Gastroentérologie Clinique et Biologique, 2004, 28, 10, 992

    CrossRef

  75. 75
    Chinyu Su, Gary R Lichtenstein, Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine, Gastroenterology Clinics of North America, 2004, 33, 2, 209

    CrossRef

  76. 76
    Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach - Volume I: Principles and Methods of Immunotoxicology, 2004,

    CrossRef

  77. 77
    Thierry Vial, Jacques Descotes, Corinna Ludwig, Matthias Behrend, 2004,

    CrossRef

  78. 78
    David B Sachar, 6-mercaptopurine beats a bum rap, Gastroenterology, 2003, 125, 2, 610

    CrossRef

  79. 79
    Current Awareness: Pharmacoepidemiology and Drug Safety, Pharmacoepidemiology and Drug Safety, 2003, 12, 1
  80. 80
    L. Biancone, C. Tosti, D. Fina, M. Fantini, F. De Nigris, A. Geremia, F. Pallone, Maintenance treatment of Crohn's disease, Alimentary Pharmacology & Therapeutics, 2003, 17,
  81. 81
    Radhika Srinivasan, James D. Lewis, Malignancies in inflammatory bowel disease, Current Opinion in Gastroenterology, 2003, 19, 4, 366

    CrossRef

  82. 82
    Andy CY Li, Saman Warnakulasuriya, Richard PH Thompson, Neoplasia of the tongue in a patient with Crohn's disease treated with azathioprine, European Journal of Gastroenterology & Hepatology, 2003, 15, 2, 185

    CrossRef

  83. 83
    Nilesh Chande, David J Tsoulis, John K MacDonald, Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease, The Cochrane Library,
  84. 84
    Conal M. Perrett, Jane M. McGregor, Catherine A. Harwood, Thiopurines and the Sun: What should be Done?,